All Articles
The Food and Drug Administration posted its analysis of Pfizer’s data ahead of a public meeting next week discussing the…
U.S. health advisers cite concern that Americans who got the single-dose shot aren’t as protected as those given two-dose brands.
Pfizer asked the U.S. Food and Drug Administration Thursday to allow use of its COVID-19 vaccine in children ages 5…
The FDA authorized booster doses for Americans 65 and older, younger people with underlying health conditions and those in high-risk…
A governmental advisory panel rejected a plan to give Pfizer COVID-19 vaccine booster shots across the board.
The state’s recommendation comes after the FDA said immunocompromised Americans can get an extra dose of the vaccine for better…
Reports say its very likely the FDA will be able to approve COVID-19 vaccinations for children under 12 before the…
Regulators added a new warning to Johnson & Johnson’s COVID-19 vaccine about links to a rare and potentially dangerous neurological…
The U.S. is recommending a “pause” in the Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood…
Pfizer put in a request to the Food and Drug Administration to adjust its emergency use authorization to children ages…
Johnson & Johnson’s single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators.
Someone removed about 50 vials of the Moderna vaccine from refrigeration and failed to return them to cold temps, so…
It's a step preliminary to the Food and Drug Administration authorizing the vaccine for emergency use. That could happen as…
FDA authorizes the first at-home, over the counter COVID-19 test that some experts have been advocating for.
President-elect Biden noted one of the deepest tragedies of the COVID-19 pandemic is its inept handling by the departing commander-in-chief.
Fauci continued to warn that while COVID-19 typically is non-fatal for young, healthy folk, it's unpredictable, leading to long-term issues.
A test that could be conducted away from a doctor "has always been a major priority," says an FDA official.…
President Trump announced the emergency authorization of convalescent plasma for COVID-19 patients, in a move he called 'a breakthrough.'